China’s Pharmaceutical Market
                         $197.00
     

For only $300 more you can buy the entire 2009 PharmaHandbook containing this report and comprehensive information on 39 additional international markets (learn more)

ORDER NOW >>

NEW! pharmahandbook - Volume Licensing Program 

VOI Consulting is pleased to announce volume licensing for our industry standard publication -- pharmahandbook.

(click for details)

Pharmahandbook Reviews:

“Thoroughly documented and clearly organized, PharmaHandbook contains a wealth of information designed for easy access. This excellent resource deserves a place on the reference shelf of anyone in the pharmaceutical or healthcare industries." BookWire

Read full review“

… PharmaHandbook is an essential resource or managers seeking to grasp the opportunities and complexities inherent in the International pharmaceutical marketplace.” About.com Bio tech and Biomedical

Major report covers impact of health reforms on China’s Pharmaceutical Market for ONLY $197!  Available for immediate download! 

Massive reforms are changing the world’s fastest growing market

By 2013, China’s pharmaceutical market will nearly triple in size to become the third largest in the world with sales of $60 billion. Alongside rapid growth, however, the industry is facing major disruptions in the operating environment as the country implements a three year $124 billion health reform that represents just the first wave of systemic changes scheduled to take place over the next decade.

Buyer characteristics, the product selection process, pricing, distribution channels, customer geographics and demographics – all of these will be profoundly different in the environment that is emerging under the new health reforms. Industry decision-makers cannot afford to ignore how these changes will affect the world’s fastest-growing market.

The Report

China: Health Reforms and the Future of the Pharmaceutical Market is a just-released report from VOI Consulting. Adapted from PharmaHandbook, our industry-leading source for comprehensive information and analysis on global pharmaceutical markets, the report explains China’s pharmaceutical market and contains in-depth coverage of health reforms, the impact they will have on the operating environment and strategies that will allow companies to capitalize on opportunities and minimize risks.

For only $197, buyers of this 50-page report will learn:

• Details of the $124 billion reforms, including how the money will be spent and who will be affected.

• The selection process for the national formulary.

• Current and emerging buyer profiles and market segmentation strategies.

• The fastest growing distribution channels.

• The rising importance of the mid-sized cities and rural areas.

• How changes in the price control regime will affect margins and customer incentives.

• How other leading companies are adapting to the changes.

• And much more.